...
首页> 外文期刊>American Journal of Pathology >Cyclooxygenase-2 Is Involved in the Up-Regulation of Matrix Metalloproteinase-9 in Cholangiocarcinoma Induced by Tumor Necrosis Factor-{alpha}
【24h】

Cyclooxygenase-2 Is Involved in the Up-Regulation of Matrix Metalloproteinase-9 in Cholangiocarcinoma Induced by Tumor Necrosis Factor-{alpha}

机译:环氧合酶-2参与肿瘤坏死因子-α诱导的胆管癌中基质金属蛋白酶9的上调。

获取原文
获取原文并翻译 | 示例
           

摘要

Matrix metalloproteinase-9 (MMP-9) is an important enzyme in tumor invasion and metastasis in malignant tumors, including cholangiocarcinoma (CC). Tumor necrosis factor- (TNF-), a proinflammatory cytokine, was recently reported to induce the up-regulation of MMP-9 in cultured CC cells. We examined whether cyclooxygenase-2 (COX-2) and prostaglandin-E2 (PGE2), another endogenous tumor promoter, are involved in the up-regulation of MMP-9 in CC using CC tissue specimens and a CC cell line, HuCCT-1. MMP-9 and COX-2 were immunohistochemically expressed in 58% and 89% of 110 CC cases, respectively; the expression of MMP-9 and COX-2 was correlated (r = 0.32, P = 0.00072). Using zymography, latent MMP-9 was detectable in all cases and active MMP-9 was detected in 24% of cases of the CC specimens. The TNF-/TNF-receptor 1 (TNF-R1) interaction induced MMP-9 production and activation, as well as COX-2 overexpression and PGE2 production, and increased the migration of CC cells. MMP-9 up-regulation was inhibited by COX inhibitors, antagonists of EP2/4 (receptors of PGE2), and COX-1 and COX-2 siRNAs. Inhibitors of both MMP-9 and MMP-9 siRNA treatment abrogated the increase in the migration of CC cells induced by TNF-. In conclusion, we propose a novel signaling pathway of MMP-9 up-regulation in CC cells such that TNF- induces the activation of COX-2 and PGE2 via TNF-R1 followed by the up-regulation of MMP-9 via the PGE2 (EP2/4) receptor.
机译:基质金属蛋白酶9(MMP-9)是在 胆管癌(CC)的恶性肿瘤中侵袭和转移的重要酶。最近报道,促炎性 细胞因子肿瘤坏死因子-(TNF-)诱导培养的CC细胞中MMP-9的上调。我们检查了环氧合酶-2 (COX-2)和前列腺素-E2(PGE2)(另一种内源性肿瘤 启动子)是否参与了MMP-9的上调。 CC使用 CC组织样本和CC细胞系HuCCT-1。在110例CC 病例中,免疫组化分别表达了MMP-9和COX-2 ; MMP-9和COX-2的表达相关(s = 0.32,P = 0.00072)。使用酶谱分析,在所有病例中均可以检测到潜伏的MMP-9,在CC标本中有24%的病例中检测到了活跃的MMP-9。 TNF- / TNF-受体1(TNF-R1) 相互作用诱导MMP-9的产生和活化,以及 COX-2过表达和PGE2产生,并增加 CC细胞的迁移。 MMP-9的上调受到 COX抑制剂,EP2 / 4拮抗剂(PGE2的受体)以及 COX-1和COX-2 siRNA的抑制。 MMP-9和MMP-9 siRNA 处理的抑制剂均消除了TNF-α诱导CC细胞 迁移的增加。总之,我们提出了CC细胞中MMP-9上调的新信号途径 ,使得TNF-通过TNF-R1诱导COX-2和PGE2的激活。然后通过PGE2(EP2 / 4)受体 上调MMP-9。

著录项

  • 来源
    《American Journal of Pathology》 |2009年第3期|829-841|共13页
  • 作者单位

    From the Departments of Human Pathology,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa|the Division of Surgical Oncology,Nagoya University Graduate School of Medicine, Nagoya;

    From the Departments of Human Pathology,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa;

    From the Departments of Human Pathology,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa|the Division of Surgical Oncology,Nagoya University Graduate School of Medicine, Nagoya;

    the Division of Surgical Oncology,Nagoya University Graduate School of Medicine, Nagoya;

    the Division of Surgical Oncology,Nagoya University Graduate School of Medicine, Nagoya;

    From the Departments of Human Pathology,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa;

    From the Departments of Human Pathology,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa;

    From the Departments of Human Pathology,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa;

    the Division of Diagnostic Pathology,Kanazawa University Hospital, Kanazawa;

    and the Department of Molecular Virology and Oncology,Cancer Institute, Kanazawa University, Kanazawa, Japan;

    and Gastroenterologic Surgery,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa;

    the Division of Surgical Oncology,Nagoya University Graduate School of Medicine, Nagoya;

    the Division of Surgical Oncology,Nagoya University Graduate School of Medicine, Nagoya;

    From the Departments of Human Pathology,Division of Cancer Medicine, Kanazawa University Graduate School of Medicine, Kanazawa;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号